Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

How Big Is The Acute Pharyngitis Market Today And What Is Its Future Size?

In recent times, the market size for acute pharyngitis has seen a robust growth. The rise from $2.67 billion in 2024 to $2.89 billion by 2025, with a compound annual growth rate (CAGR) of 8.2% depicts this positive trend. Factors such as the escalating incidences of viral and bacterial infections, enhanced healthcare awareness, improved diagnostic technologies, and an increasing count of pediatric cases, along with the rise in environmental pollutants and allergen factors have contributed to the growth in the historical period.

Expectations are high for the acute pharyngitis market, as it is forecasted to experience solid expansion in the forthcoming years. The market is predicted to reach $3.95 billion in 2029, with an 8.1% compound annual growth rate (CAGR) on the cards. Factors such as an increase in influenza and streptococcal infections, a stronger emphasis on personalized medicine, the emergence of rapid diagnostic tests, enhancements in healthcare infrastructure, and wider accessibility of healthcare in developing markets are believed to be the driving forces of this projected growth. It’s also expected to witness various trends in the forecast period including a move towards treatments available over-the-counter, heightening the use of combined therapies, a surge in telemedicine for diagnosing pharyngitis, the emergence of organic and substitute remedies, and an increased inclination for self-treatment and home-based therapies.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21082&type=smp

Which Key Factors Are Fueling Growth In The Acute Pharyngitis Market?

Expectations for the acute pharyngitis market’s expansion are being driven by an increased occurrence of influenza. Influenza, a condition resulting from infection with influenza viruses, is transmitted via respiratory droplets from coughs or sneezes, or by touching infected surfaces. The surge in influenza rates can be attributed to several factors such as changes in seasons, poor vaccination coverage, enhanced human mobility, virus mutations, and compromised immunity among certain demographics. The treatment for acute pharyngitis benefits those with influenza as it relieves throat inflammation and discomfort during swallowing, avert secondary bacterial infections, and aids overall recovery. This, when paired with antiviral medicines, sufficient hydration, and rest, bolsters the body’s defense against the influenza virus. For example, the Centers for Disease Control and Prevention, a US government agency, reported that as of February 2025, the share of clinical lab tests positive for influenza had risen to 31.6%, a jump from 29.4% the preceding week and 18.6% at the beginning of the year. Hence, the escalating occurrence of influenza is propelling the acute pharyngitis market’s growth.

How Is The Acute Pharyngitis Market Segmented Across Key Categories?

The acute pharyngitismarket covered in this report is segmented –

1) By Treatment: Antibiotics; Antivirals; Over-the-Counter (OTC) Medications; Corticosteroids And Anti-inflammatory Drugs; Alternative Remedies

2) By Distribution Channel: Hospital Pharmacy; Online Pharmacy; Retail Pharmacy

3) By End-User: Hospitals; Homecare; Speciality Centres; Other End Users

Subsegments:

1) By Antibiotics: Penicillins; Cephalosporins; Macrolides

2) By Antivirals: Neuraminidase Inhibitors; Nucleoside Analogs

3) By Over-the-Counter (OTC) Medications: Analgesics; Throat Lozenges; Cough Syrups

4) By Corticosteroids And Anti-inflammatory Drugs: Glucocorticoids; Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)

5) By Alternative Remedies: Herbal Teas; Honey-Based Solutions; Saltwater Gargles

What Future-Focused Trends Are Anticipated In The Acute Pharyngitis Market?

Leading firms in the acute pharyngitis industry are concentrating on the creation of antibiotics to fight bacterial infections more effectively and limit antibiotic resistance. Treating acute pharyngitis, particularly when caused by bacterial infections like streptococcus pyogenes, heavily relies on antibiotics, which help eradicate the bacteria, alleviate symptoms, and fend off complications such as rheumatic fever. For example, in February 2022, Alembic Pharmaceuticals Limited, a pharmaceutical company based in India, obtained Abbreviated New Drug Application (ANDA) authorization for Clarithromycin tablets USP, 250 mg and 500 mg, from the Food & Drug Administration (USFDA), a governmental agency in the United States. This macrolide antibiotic is designed to treat mild to moderate bacterial infections, including pharyngitis or tonsillitis, community-acquired pneumonia, and chronic bronchitis. This approval highlights the critical role of effective antimicrobial treatments in managing acute pharyngitis and associated bacterial infections.

Who Are The Leading Companies Driving The Acute Pharyngitis Market?

Major companies operating in the acute pharyngitis market are Pfizer Inc., Johnson & Johnson, AbbVie Inc., Merck & Co. Inc., Sanofi S.A., Bristol-Myers Squibb, AstraZeneca plc, Novartis AG, Glaxo Smithkline Pharmaceuticals Ltd, F. Hoffmann-La Roche AG, Eli Lilly and Company, Amgen Inc., Boehringer Ingelheim, Teva Pharmaceutical Industries Ltd., Mylan N.V., Sandoz Group AG, Bitop AG, Hikma Pharmaceuticals, Lupin Limited, Alkem Laboratories Ltd., MEDICE Arzneimittel Pütter GmbH & Co. KG, MCM Klosterfrau Vertriebsgesellschaft mbH

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/acute-pharyngitis-global-market-report

Which Region Dominates The Acute Pharyngitis Market Today?

North America was the largest region in the acute pharyngitis market in 2024. The regions covered in the acute pharyngitis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=21082&type=smp

Browse Through More Reports Similar to the Global Acute Pharyngitis Market 2025, By The Business Research Company

Pharyngitis Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pharyngitis-treatment-global-market-report

Bacterial And Plasmid Vector Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/bacterial-and-plasmid-vector-global-market-report

Antibacterial Products Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/antibacterial-products-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model